Thermidas is a Finnish health technology company established in 2008. We’re dedicated to developing and advancing infrared (IR) thermal imaging for diagnostic use. From the very beginning, the company has invested in the research and development of IR thermal imaging in various medical applications.
The IR thermal imaging technology developed by Thermidas has been applied in different University research projects and is in clinical use in several University Hospitals and private clinics in Finland. The company has recently expanded its presence also in markets outside Finland and has offices in the UK, Germany and the USA.
TherMidas has two business areas, one focusing on medical conditions, and the other, Thermidas VET, on veterinary applications.
The tremendous technological development of the last few decades has allowed IR thermal imaging to emerge as a novel, significant diagnostic imaging method alongside conventional imaging methods.
Thermidas has received FDA 510(k) clearance in January 2021.
Indications for Use:
The Thermidas IR System is for adjunctive use in addition to other clinical diagnostic procedures for diagnostic imaging for thermally significant indications of all skin regions of the human body. The system is for reviewing and reporting of temperature patterns and changes. The significance of the value of these thermal patterns is determined by professional investigation. The system is not intended for absolute temperature measurements. The Thermidas IR system is intended for use by trained technical personnel.
Thermidas has been assessed and certified as meeting the requirements of ISO 13485:2016 certificate for design and manufacturing of infrared systems for medical purposes.
ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements.